Dr. Michael Schofield Phipps, MD

Dr. Phipps practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Phipps' NPI, 1457534745, was assigned on December 10, 2007. Dr. Phipps holds Maryland license D0076715.

Dr. Phipps' primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Phipps' primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Phipps is also affiliated with University of Maryland Rehabilitation & Orthopaedic Institute. The medical group on file is University of Maryland Neurology Associates, P.A. Dmand AI also links Dr. Phipps to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Phipps practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular neurology is Dr. Phipps' primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Dmand AI has Dr. Phipps' licenses on file in 2 states: Maryland and Connecticut.

CMS data shows 250 Medicare services from Dr. Phipps across 6 procedure codes in 2024, for 139 Medicare patients. Medicare paid $20,570 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 139 Medicare patients who saw Dr. Phipps in 2024. The largest group is 75 to 84, with 53 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Phipps' median patient age at 65, with 54% women.

In 2024, Dr. Phipps wrote 183 Medicare Part D claims for 33 patients. 93% of them were for generic drugs. CMS names the drug for 93 of them, across 6 drugs with 11 or more claims each, at $2,750 in total drug cost. In 2023, CMS named 63 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Phipps for performance year 2024, reported as part of a group. Dr. Phipps accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Phipps as offering telehealth.

Dmand AI links 52 papers to Dr. Phipps, published from 2010 to 2024. 2021 was the busiest year, with 9. The most frequent topics are Stroke, Brain Ischemia and Ischemic Stroke. Dr. Phipps has published most often in Neurology. Dr. Phipps' most frequent co-authors are Marcella A. Wozniak, MD, Carolyn Anne Cronin, MD, PhD and Seemant Chaturvedi, MD.

CMS Open Payments shows 3 general payments to Dr. Phipps from 3 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 100% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $29.